Evidence map›Paper›PMID 41497679›Full record

ReviewWorld journal of experimental medicine2025

Pinocembrin as a novel anti-cancer agent: Exploring preclinical evidence along with therapeutic potential.

Neelam Singla, Piyush Mittal, M Arockia Babu, Soumya V Menon, Subhashree Ray, Haider Ali, Manish Purohit, Kavita Goyal, Rakhi Mishra, Md Sadique Hussain and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Neelam SinglaSchool of Pharmacy, Suresh Gyan Vihar University, Jaipur 302017, Rajasthan, India.
Piyush MittalSchool of Pharmacy, Sharda University, Greater Noida 201306, India.
M Arockia BabuInstitute of Pharmaceutical Research, GLA University, Mathura 281406, Uttar Pradesh, India.
Soumya V MenonDepartment of Chemistry and Biochemistry, Jain (Deemed to be University), Bengaluru 560041, Karnataka, India.
Subhashree RayDepartment of Nephrology IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhuban 751003, Odisha, India.
Haider AliCentre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 602105, Tamil Nadu, India.
Manish PurohitSchool of Pharmacy, Suresh Gyan Vihar University, Jaipur 302017, Rajasthan, India.
Kavita GoyalDepartment of Biotechnology, Graphic Era (Deemed to be University), Dehra Dun 248002, Uttarakhand, India.
Rakhi MishraNoida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida 201306, India.
Md Sadique HussainUttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehra Dun 248007, Uttarakhand, India.
Arcot RekhaDr. D.Y. Patil Medical College, Hospital and Research Centre, Pune 411018, Maharashtra, India.
Gaurav GuptaCentre for Research Impact and Outcome-Chitkara College of Pharmacy, Chitkara University, Rajpura 433221, Punjab, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pinocembrin (PB) (5,7-dihydroxy flavanone) is a naturally occurring flavonoid sourced from propolis and Pinus spp., with the formula C

Indexed as

Anticancer activityApoptosisFlavonoidNanoparticle deliveryPharmacokineticsPinocembrin

Identifiers

PMID41497679
PMCPMC12767260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.